...

Appointment

Are you interested in our service? Book an appointment today.

    Working Hour

    • 8:00 - 18:00
    • 8:00 - 18:00
    • 8:00 - 18:00
    • 8:00 - 18:00
    • 8:00 - 18:00
    • 8:00 - 18:00
    • 8:00 - 18:00

    Karyotyping for Prenatal Testing

    Karyotyping is a laboratory technique used to visualize and analyze the number, shape, and size of chromosomes in a sample of cells. In the context of prenatal testing, karyotyping helps to identify chromosomal abnormalities that might affect a developing fetus.

    Purpose

    Prenatal karyotyping is used to: Confirm or rule out suspected chromosomal disorders based on other screening tests.
    Determine the cause of fetal anomalies detected on ultrasound.
    Evaluate the risk of chromosomal abnormalities in pregnancies where the mother is of advanced maternal age or there’s a family history of chromosomal disorders.

    Procedure

    Sample Collection: Cells for karyotyping can be obtained using one of the following methods:
    Chorionic Villus Sampling (CVS): Performed between 10 to 13 weeks of pregnancy, this procedure involves removing a small sample of cells from the placenta.
    Amniocentesis: Conducted between 15 to 20 weeks of pregnancy, this involves extracting a sample of amniotic fluid containing fetal cells.
    Cell Culture: The obtained cells are cultured in a laboratory to increase their number.
    Chromosome Staining & Visualization: Chromosomes are stained and visualized under a microscope.
    Analysis: Chromosomes are arranged in pairs by size, from largest to smallest, creating a visual profile known as a karyogram or karyotype. The karyotype is then examined for abnormalities in chromosome number or structure.

    Results

    A normal human karyotype will show 46 chromosomes arranged as 22 pairs of autosomes and one pair of sex chromosomes. Abnormal results might reveal: Aneuploidies: An abnormal number of chromosomes, such as trisomy 21 (Down syndrome), where there are three copies of chromosome 21 instead of the usual two. Structural abnormalities: Such as deletions, translocations, inversions, or duplications in chromosome structure.

    Clinical Implications

    Informed Decision Making: Based on the results, parents can make informed decisions about the pregnancy and prepare for the potential needs of the child after birth.
    Planning Medical Care: Identifying certain chromosomal disorders prenatally can help healthcare providers plan for necessary medical interventions immediately after birth.

    Considerations

    Invasive Procedures: Both CVS and amniocentesis are invasive procedures and carry a slight risk of miscarriage.
    Not Comprehensive: Karyotyping can detect large-scale chromosomal abnormalities but may not identify small genetic mutations responsible for other genetic disorders.
    Emotional Impact: Receiving a diagnosis of a chromosomal disorder can be emotionally challenging for expecting parents.
    Counseling: Genetic counseling is vital both before and after the test to help parents understand the results and implications.

    Conclusion

    Prenatal karyotyping is a valuable tool for detecting chromosomal abnormalities in a developing fetus. It offers detailed insights that can help parents make informed decisions regarding their pregnancy and prepare for the future. As with all medical procedures, it’s essential to understand the benefits, risks, and limitations, and to be supported by appropriate counseling.

    Onco-Genomics is the first in-house DNA & oncological testing Centre in West Africa. We specialize in advanced genetic testing across various life stages, ensuring your family’s health and well-being are always at the forefront.

    Facebook-f Linkedin Instagram
    Quick Links
    Get In Touch

    © Onco-Genomics. All Rights Reserved. Designed by UpperMark Solutions Limited

    Seraphinite AcceleratorOptimized by Seraphinite Accelerator
    Turns on site high speed to be attractive for people and search engines.